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Objectives: We determined 1) whether epithelial cell intercellular junctions (ICJ) are key boundaries in limiting EHV1 infection in the respiratory tract and 2) which factors affect these ICJ.
Study design: Ex vivo experiments.
Methods: Equine respiratory mucosal explants were treated with various agents (e.g. EGTA, Lysomucil â , pollen proteases) to disrupt ICJ, prior to inoculation with EHV1. Destruction of ICJ was assessed by microscopic image analysis of haematoxylin-eosin stainings. EHV1 replication in explants was visualised by immunofluorescence staining and confocal microscopy. Experiments in explants were corroborated in in vitro equine respiratory epithelial cells (EREC), which were inoculated at either the apical or the basolateral surfaces, following destruction of their ICJ.
Results:
The drugs affecting cellular calcium levels (EGTA and Lysomucilâ), together with pollen proteases were able to alter ICJ. Subsequent EHV1 binding to and infection of explants was greatly enhanced upon destruction of ICJ. In addition, EHV1 preferentially bound to and entered EREC at basolateral cell surfaces.
Main limitations: Although ex vivo explants most likely reflect what happens in the horse, our findings need to be validated using in vivo studies.
Conclusions:
We demonstrated that integrity of the horse's respiratory epithelium is crucial in the defence against an EHV1 infection. Veterinarians should be cautious when using Lysomucil â in the aerosol therapy of horses. Finally, it can be postulated that during pollen season, some horses might have a deficiency in epithelial integrity and therefore be more receptive for an EHV1 infection and shed EHV1 more easily towards other horses. Background: Dembrexine is a widely used secretolytic drug in respiratory diseases of horses, including equine asthma. Efficacy has been demonstrated in laboratory animals, based on pronounced expectorant effect, a secondary antitussive action, and increased lung compliance, but independent clinical trials in horses suffering from equine asthma have not been performed.
Objectives:
The aim of our study was to investigate the efficacy of dembrexine as a mucolytic drug in horses diagnosed with mild (inflammatory airway disease, IAD) or moderate to severe (recurrent airway obstruction, RAO) equine asthma.
Study design: Randomised, placebo-controlled clinical trial.
Methods: Sixteen treated horses and eight control horses, all suffering from equine asthma, were included in the study. Each horse was examined three times, on Days 0, 14 and 28. Examinations included physical examination, respiratory endoscopy, collection of tracheal mucus and bronchoalveolar lavage fluid (BALF), thoracic ultrasonography, haematology, culture and rheological analysis of tracheal mucus, and cytology of BALF. Dembrexine (Sputolysin powder, Boehringer Ingelheim, Budapest, Hungary) was administered orally to each horse in the treatment group at a dose of 0.3 mg/kg bwt twice daily for 28 days. Control horses received the same amount of glucose powder. Data was analysed by descriptive statistics, tests for normality, paired t tests and repeated measures analysis of variance. P<0.05 was considered significant.
Results: Tracheal mucus score decreased (P<0.01), and the value of damping factor of tracheal mucus increased (P = 0.04) significantly in the treatment group in contrast to those of the control group.
Main limitations: Low number of horses were included. Horses were kept in different stables during the study, therefore different stabling conditions and air quality might have influenced the results.
